"6"^^ . "Zav\u0159elov\u00E1, J." . "Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia"@en . . "Thrombohaemorrhagic syndrome is a clinical syndrome manifesting with concurrent bleeding and thrombosis. It is associated with a range of pathological states, typically with myeloproliferative diseases, paraproteinaemia, liver disease as well as disseminated intravascular coagulation and similar syndromes (so called DIC-like syndrome). Thrombohaemorrhagic syndrome might be a symptom of chronic myeloproliferations, particularly if these are associated with thrombocythemia. It is most frequently linked to essential thrombocythemia. However, in this disease, it seems that the clinical symptoms of bleeding and thrombosis might not be directly determined by the number of platelets, as it would suggest itself, but that this can be consequent to other changes. These may include predisposition to thrombophilia, cardiovascular risk, leukocytosis etc. as well as, for example, platelet dysfunction. The present study focuses on platelet dysfunction in conjunction with clinical symptoms of bleeding and thrombosis."@en . "V" . "Ovesn\u00E1, Petra" . "5"^^ . "Trombohemoragick\u00FD syndrom u nemocn\u00FDch s myeloproliferativn\u00EDm onemocn\u011Bn\u00EDm s trombocytemi\u00ED"@cs . "Kissov\u00E1, Jarmila" . "Thrombohaemorrhagic syndrome in patients with a myeloproliferative disease with thrombocythemia"@en . "3" . . "Trombohemoragick\u00FD syndrom u nemocn\u00FDch s myeloproliferativn\u00EDm onemocn\u011Bn\u00EDm s trombocytemi\u00ED" . . "Thrombohaemorrhagic syndrome; bleeding; platelet"@en . "Pavl\u00EDk, Tom\u00E1\u0161" . . . . "CZ - \u010Cesk\u00E1 republika" . . . . . . . . "Bulikov\u00E1, Alena" . "236124" . "Penka, Miroslav" . . . "[755C82D4D690]" . . . "RIV/00216224:14110/11:00052916!RIV12-MSM-14110___" . "Vnit\u0159n\u00ED l\u00E9ka\u0159stv\u00ED" . "Trombohemoragick\u00FD syndrom je klinick\u00FD syndrom projevuj\u00EDc\u00ED se sou\u010Dasn\u00FDm v\u00FDskytem krv\u00E1cen\u00ED a tromb\u00F3zy. Vyskytuje se v souvislosti s \u0159adou chorobn\u00FDch stav\u016F a je p\u0159\u00EDzna\u010Dn\u00FD pro myeloproliferativn\u00ED choroby, paraproteinemie a jatern\u00ED choroby. D\u00E1le se objevuje v souvislosti s diseminovanou intravaskul\u00E1rn\u00ED koagulac\u00ED a j\u00ED podobn\u00FDmi syndromy (tzv. DIC-like syndrom). Trombohemoragick\u00FD syndrom m\u016F\u017Ee b\u00FDt projevem chronick\u00FDch myeloproliferac\u00ED, zejm\u00E9na jsou-li prov\u00E1zeny trombocytemi\u00ED. Nej\u010Dast\u011Bji tedy prov\u00E1z\u00ED esenci\u00E1ln\u00ED trombocytemii. U tohoto onemocn\u011Bn\u00ED se v\u0161ak ukazuje, \u017Ee se nemus\u00ED jednat o bezprost\u0159edn\u00ED z\u00E1vislost klinick\u00E9 symptomatologie krv\u00E1cen\u00ED a tromb\u00F3zy na po\u010Dtu krevn\u00EDch desti\u010Dek, jak by se nab\u00EDzelo, ale \u017Ee m\u016F\u017Ee b\u00FDt d\u016Fsledkem i jin\u00FDch zm\u011Bn. Z nich se vedle sou\u010Dasn\u00E9 p\u0159\u00EDtomnosti rizikov\u00FDch trombofiln\u00EDch dispozic, kardiovaskul\u00E1rn\u00EDho rizika, leukocyt\u00F3zy a dal\u0161\u00EDch nab\u00EDzej\u00ED poruchy funkce krevn\u00EDch desti\u010Dek." . "Trombohemoragick\u00FD syndrom u nemocn\u00FDch s myeloproliferativn\u00EDm onemocn\u011Bn\u00EDm s trombocytemi\u00ED"@cs . "0042-773X" . "5"^^ . "57" . "RIV/00216224:14110/11:00052916" . "Trombohemoragick\u00FD syndrom u nemocn\u00FDch s myeloproliferativn\u00EDm onemocn\u011Bn\u00EDm s trombocytemi\u00ED" . "Trombohemoragick\u00FD syndrom je klinick\u00FD syndrom projevuj\u00EDc\u00ED se sou\u010Dasn\u00FDm v\u00FDskytem krv\u00E1cen\u00ED a tromb\u00F3zy. Vyskytuje se v souvislosti s \u0159adou chorobn\u00FDch stav\u016F a je p\u0159\u00EDzna\u010Dn\u00FD pro myeloproliferativn\u00ED choroby, paraproteinemie a jatern\u00ED choroby. D\u00E1le se objevuje v souvislosti s diseminovanou intravaskul\u00E1rn\u00ED koagulac\u00ED a j\u00ED podobn\u00FDmi syndromy (tzv. DIC-like syndrom). Trombohemoragick\u00FD syndrom m\u016F\u017Ee b\u00FDt projevem chronick\u00FDch myeloproliferac\u00ED, zejm\u00E9na jsou-li prov\u00E1zeny trombocytemi\u00ED. Nej\u010Dast\u011Bji tedy prov\u00E1z\u00ED esenci\u00E1ln\u00ED trombocytemii. U tohoto onemocn\u011Bn\u00ED se v\u0161ak ukazuje, \u017Ee se nemus\u00ED jednat o bezprost\u0159edn\u00ED z\u00E1vislost klinick\u00E9 symptomatologie krv\u00E1cen\u00ED a tromb\u00F3zy na po\u010Dtu krevn\u00EDch desti\u010Dek, jak by se nab\u00EDzelo, ale \u017Ee m\u016F\u017Ee b\u00FDt d\u016Fsledkem i jin\u00FDch zm\u011Bn. Z nich se vedle sou\u010Dasn\u00E9 p\u0159\u00EDtomnosti rizikov\u00FDch trombofiln\u00EDch dispozic, kardiovaskul\u00E1rn\u00EDho rizika, leukocyt\u00F3zy a dal\u0161\u00EDch nab\u00EDzej\u00ED poruchy funkce krevn\u00EDch desti\u010Dek."@cs . . "14110" . .